Discover open access scientific publications

Search, annotate, share and cite publications

Publications by T. Gilewski

A Feasibility Study of Bevacizumab Plus Dose-Dense Doxorubicin-Cyclophosphamide (AC) Followed by Nanoparticle Albumin-Bound Paclitaxel in Early-Stage Breast Cancer

Clinical Cancer Research

Cancer Research

Oncology

2011

English

Related publications

P2-033Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel Dose Dense in Stage III Breast Cancer

English

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-Per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

Journal of Clinical Oncology

English

Targeted Delivery for Breast Cancer Therapy: The History of Nanoparticle-Albumin-Bound Paclitaxel

Expert Opinion on Pharmacotherapy

Medicine

Pharmacology

2010

English

Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)

Scientific Reports

Multidisciplinary

2019

English

Nanoparticle Albumin-Bound-Paclitaxel: A Limited Improvement Under the Current Therapeutic Paradigm of Pancreatic Cancer

Expert Opinion on Pharmacotherapy

Medicine

Pharmacology

2015

English

Targeted Delivery of Albumin Bound Paclitaxel in the Treatment of Advanced Breast Cancer

OncoTargets and Therapy

Oncology

Pharmacology

2009

English

Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer

Journal of Clinical Oncology

English

Weekly Intravenous Nanoparticle Albumin-Bound Paclitaxel for Elderly Patients With Stage IV Non-Small-Cell Lung Cancer: A Series of 20 Cases

Journal of Biomedical Research

English

Fifteen-Year Median Follow-Up Results After Neoadjuvant Doxorubicin, Followed by Mastectomy, Followed by Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Followed by Radiation for Stage III Breast Cancer: A Phase II Trial (CALGB 8944)

Breast Cancer Research and Treatment

Cancer Research

Oncology

2008

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by T. Gilewski

A Feasibility Study of Bevacizumab Plus Dose-Dense Doxorubicin-Cyclophosphamide (AC) Followed by Nanoparticle Albumin-Bound Paclitaxel in Early-Stage Breast Cancer

Related publications

P2-033Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel Dose Dense in Stage III Breast Cancer

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-Per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

Targeted Delivery for Breast Cancer Therapy: The History of Nanoparticle-Albumin-Bound Paclitaxel

Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)

Nanoparticle Albumin-Bound-Paclitaxel: A Limited Improvement Under the Current Therapeutic Paradigm of Pancreatic Cancer

Targeted Delivery of Albumin Bound Paclitaxel in the Treatment of Advanced Breast Cancer

Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer

Weekly Intravenous Nanoparticle Albumin-Bound Paclitaxel for Elderly Patients With Stage IV Non-Small-Cell Lung Cancer: A Series of 20 Cases

Fifteen-Year Median Follow-Up Results After Neoadjuvant Doxorubicin, Followed by Mastectomy, Followed by Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Followed by Radiation for Stage III Breast Cancer: A Phase II Trial (CALGB 8944)